Review
Sep 2026
Beyond Zolbetuximab: Next-Generation Targeting Strategies for CLDN18.2
T. Sagawa, H. Nagashima, K. Fujikawa
· Journal of Gastrointestinal... · 0 citations
We have 5 of 64 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Review
Aug 2026
BRAF V600E-Mutated Metastatic Colorectal Cancer: Practical Management in the Post-BREAKWATER Era
T. Sagawa, H. Nagashima, K. Fujikawa
· Journal of Gastrointestinal... · 0 citations
Review
Sep 2026
Emerging Therapeutic Strategies for Non-G12C KRAS Mutations in Colorectal Cancer: Focusing on G12D and G12V
T. Sagawa, Masahiro Hirakawa, H. Nagashima et al.
· Journal of Gastrointestinal... · 0 citations
Review
Aug 2026
HER2-Targeted Therapy for Metastatic Colorectal Cancer: Current Evidence, Patient Selection, and Practical Treatment Sequencing
T. Sagawa, H. Nagashima, K. Fujikawa
· Journal of Gastrointestinal... · 0 citations
Review
Aug 2026
KRAS G12C-mutated Metastatic Colorectal Cancer: Current Therapeutic Strategies and Future Directions
The biologic rationale, current clinical evidence, practical guideline-based positioning, practical guideline-based positioning, toxicity management considerations, resistance mechanisms, and emerging therapeutic strategies for KRAS G12C-mutated mCRC are summarized.
T. Sagawa, H. Nagashima, K. Fujikawa
· Journal of Gastrointestinal... · 0 citations